Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]
News [12614]
Articles [173]
Editorials [5]
Conferences [246]
elearning [17]
A new anti-CD22 CAR T immunotherapy for paediatric leukaemia
Dr Jing Pan - Beijing Boren Hospital, Beijing, China
A new anti-CD22 CAR T immunotherapy for paediatric leukaemia ( Dr Jing Pan - Beijing Boren Hospital, Beijing, China )
16 Jun 2018
EHA Topics in focus : Immunotherapy
Prof John Gribben - Barts Cancer Institute, London, United Kingdom
EHA Topics in focus : Immunotherapy ( Prof John Gribben - Barts Cancer Institute, London, United Kingdom )
16 Jun 2018
Novel ADC for relapsed/refractory lymphoma
Dr Laurie Sehn - BC Cancer Agency, Vancouver, Canada
Novel ADC for relapsed/refractory lymphoma ( Dr Laurie Sehn - BC Cancer Agency, Vancouver, Canada )
16 Jun 2018
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma
Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo...
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma ( Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Chng )
15 Jun 2018
EHA 2018: Results of the OPTIMISMM trial
Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
EHA 2018: Results of the OPTIMISMM trial ( Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA )
15 Jun 2018
Updated results from a phase I trial of CAR-T cell therapy for r/rMM
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Updated results from a phase I trial of CAR-T cell therapy for r/rMM ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
15 Jun 2018
Fatigue at baseline predicts shorter survival in older patients with a...
Prof Reinhard Stauder - University of Innsbruck, Innsbruck, Austria
Fatigue at baseline predicts shorter survival in older patients with a haematological malignancy ( Prof Reinhard Stauder - University of Innsbruck, Innsbruck, Austria )
15 Jun 2018
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma
Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma ( Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina )
15 Jun 2018
Updates from Myeloma XI trial
Dr Charlotte Pawlyn - The Institute of Cancer Research, London, UK
Updates from Myeloma XI trial ( Dr Charlotte Pawlyn - The Institute of Cancer Research, London, UK )
15 Jun 2018
Ribosomal lesions promote oncogenic mutagenesis
Dr Sergey Sulima - Katholieke Universiteit Leuven, Lueven, Belgium
Ribosomal lesions promote oncogenic mutagenesis ( Dr Sergey Sulima - Katholieke Universiteit Leuven, Lueven, Belgium )
15 Jun 2018
Updated data from the FORTE trial of carfilzomib plus lenalidomide or...
Dr Francesca Gay - University of Torino, Torino, Italy
Updated data from the FORTE trial of carfilzomib plus lenalidomide or cyclophosphamide for myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )
15 Jun 2018
Rituximab in combination therapies for FL: Interim results
Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France
Rituximab in combination therapies for FL: Interim results ( Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France )
15 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation